The backtest results show that DHR has a 70% win rate and a 1.63% average return over 30 days following earnings beats, despite negative short-term returns. This indicates a stronger positive price reaction in the medium term rather than immediately after the event. The maximum return observed was 0.17%, occurring on the event day, suggesting limited immediate upside.

These results imply that investors may benefit from holding DHR for a longer period post-earnings beat to capture gains. Short-term trading around the event may be less rewarding due to initial negative returns.

Investors should consider a medium-term holding strategy to capitalize on DHR's earnings beat effects.

backtest_data

The backtest results show that DHR experienced negative returns following earnings misses, with a 3-day win rate of 25% and a 30-day return of -6.88%. This indicates a consistent downward trend in the stock price after earnings disappointments. The maximum return observed was only 1.16%, occurring 40 days post-event, suggesting limited recovery potential in the short to medium term.

These results highlight the adverse market reaction to DHR's earnings misses, reflecting investor concerns about the company's performance. Investors should be cautious and consider the potential for sustained declines when DHR reports earnings below expectations.

This pattern suggests a defensive approach may be warranted around DHR earnings misses to mitigate downside risk.

The backtest results show that the Life Sciences Tools & Services Industry experienced no significant impact following earnings beats, with a maximum return of only 0.86% occurring on day 4. This indicates that earnings beats in this sector do not translate into meaningful price movements over the tested period.

The lack of a strong market reaction suggests that investors may already price in earnings beats or that other factors dominate stock performance in this industry.

For investors, this implies limited benefit from trading on earnings beats alone within this sector.

The backtest results show that earnings misses in the Life Sciences Tools & Services Industry occurred 87 times between 2023 and 2025, with no significant impact on the industry's performance. The maximum return observed was 10.34% on day 38, indicating no consistent negative or positive trend following these events. This suggests that earnings misses in this sector do not reliably affect stock returns. Investors might consider that such earnings misses in this industry are not strong indicators for short- or medium-term investment decisions.

The backtest results reveal a positive market impact following Danaher's earnings beat, with the Semiconductors and Semiconductor Equipment industry showing strong gains over 54 days. In contrast, the Healthcare Equipment and Supplies sector experienced a negative impact, likely due to sector rotation. This divergence highlights investor preference shifting towards technology-driven industries after Danaher's strong performance.

The analysis suggests that Danaher's earnings beat signals robust demand and innovation in tech sectors, driving capital investment in semiconductors while traditional healthcare equipment faces profit-taking pressure.

Investors might consider overweighting semiconductor-related stocks post-Danaher earnings beat while being cautious on healthcare equipment exposure.

backtest_industry_impact_data

The backtest results reveal that Danaher's earnings miss led to a significant negative impact on the Life Sciences Tools industry, with prolonged declines over 56 days. Conversely, the Household Products sector experienced a positive uplift for 49 days, reflecting a defensive rotation. This divergence highlights a market shift away from growth-sensitive health care sectors toward more stable consumer staples following disappointing earnings.

The analysis suggests that investors react to earnings misses by reducing exposure to vulnerable industries while favoring defensive sectors for stability.

Investment insight points to potential opportunities in Household Products as a safe haven during health sector earnings disappointments.

Backtest DHR Earnings Beat Expectations

Find all upcoming company earnings reports scheduled for jan 28 2026. Get details on which companies are reporting and their expected results.

Calendar